Skip to main content
Year archive

Fresenius SE & Co. KGaA — 2023 filings

All 34 regulatory filings released by Fresenius SE & Co. KGaA (FRE) in 2023, sourced directly from the official regulator.

34 Filings
2023 Period
2023 filings (34)
Filing Released Lang
Report Publication Announcement 2023
Report Publication Announcement
2023-12-11 English
Report Publication Announcement 2023
Report Publication Announcement
2023-12-11 English
Report Publication Announcement 2023
Report Publication Announcement
2023-12-11 English
Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to 300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023
Notice of Dividend Amount
2023-12-05 English
Declaration of Conformity of Fresenius SE & Co. KGaA as of December 2023
Governance Information
2023-12-01 English
Entsprechenserklärung der Fresenius SE & Co. KGaA vom Dezember 2023
Governance Information
2023-12-01 German
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report Q3 2023
2023-11-06 English
Conference Call Q3 Results 2023, Fresenius
Investor Presentation
2023-11-02 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-08-17 English
Fresenius SE & Co. KGaA: Dr. Michael Moser, buy
Director's Dealing
2023-08-04 English
Half-yearly financial report 2023
Interim / Quarterly Report H1 2023
2023-08-04 English
Conference Call Q2 Results 2023, Fresenius
Investor Presentation
2023-08-02 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-07-03 English
Satzung der Fresenius SE & Co. KGaA (15. Juni 2023)
Governance Information
2023-06-15 German
Articles of Association of Fresenius SE & Co. KGaA (June 15, 2023)
Regulatory Filings
2023-06-15 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-05-30 English
Conference Call Q1 Results 2023, Fresenius
Investor Presentation
2023-05-11 English
Q1 statement / Q1 financial report 2023
Interim / Quarterly Report Q1 2023
2023-05-11 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-05-08 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-04-25 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-04-25 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-04-18 English
Fresenius SE & Co. KGaA: Sara Hennicken, buy
Director's Dealing
2023-04-03 English
Fresenius SE & Co. KGaA: Michael Sen, buy
Director's Dealing
2023-04-03 English
Annual financial report 2022
Annual Report FY 2022
2023-03-24 English
Corporate Governance Declaration and Report 2022 of Fresenius SE & Co. KGaA
Governance Information
2023-03-23 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-03-21 English
Barclays – Global Healthcare Conference
Investor Presentation
2023-03-15 English
Credit Suisse Global Healthcare Conference
Investor Presentation
2023-03-01 English
Erklärung zur Unternehmensführung und Corporate Governance Bericht 2022 der Fresenius SE & Co. KGaA
Governance Information
2023-03-01 German
Morgan Stanley, European MedTech & Services Conference
Investor Presentation
2023-02-28 English
Conference Call FY 2022, Fresenius
Investor Presentation
2023-02-22 English
Fresenius SE & Co. KGaA: Outlook 2023 Fresenius advances with deconsolidation of Fresenius Medical Care by changing its legal form into a German stock corporation (Aktiengesellschaft)
Regulatory Filings
2023-02-21 English
Fresenius SE & Co. KGaA: Fresenius SE & Co. KGaA confirms review of deconsolidation of Fresenius Medical Care through change of legal form into a stock corporation
Regulatory Filings
2023-02-09 English